Dr. Micha Abeles

Four Decades Advancing the Study of Rheumatology

An alumnus of Cornell University, Dr. Micha Abeles earned his BA in 1967 before earning admission to State University of New York, Buffalo School of Medicine and Biomedical Science, where he earned his MD degree. Graduating in 1971, Dr.Abeles went on to complete an internship and residency through the University of Buffalo program. Following his residency in 1974, he served for several years in the US Army, stationed at Fort Monroe, where he served as director of the rheumatology clinic, as well as chief of the outpatient department.

Leaving the army in 1976, Dr.Abeles did his rheumatology fellowship University of Connecticut Health Center.In 1978 he was appointed an assistant professor of medicine in the division of rheumatology as well as director of the third year medical student clerkship program.

Over the next four decades he remained at the University of Connecticut,being associate director of the NIH funded multipurpose arthritis center as well as teaching students, interns, residents and fellows and conducting research on rheumatological conditions and their treatments. Before retiring from the university in 2016, he served as a professor of medicine in the division of rheumatology, and chief of the section of rheumatology. He is one of the authors of the 1990 fibromyalgia criteria paper.

Currently Dr Abeles and his son Dr. Aryeh M. Abeles, have a rheumatology practice in Meriden, CT.

National Public Policy Summit on Lupus Addresses Congress in June 2017

A doctor in private practice in Meriden, Connecticut, Dr. Micha Abeles has more than four decades of experience treating rheumatic diseases including rheumatoid arthritis, lupus, and osteoarthritis. Dr. Micha Abeles serves on the Board of Directors of the Connecticut Chapter of the Lupus Foundation of America, which will host its National Public Policy Summit on Lupus in June 2017.

Part of the National Policy Summit: Advocacy in Action series, the Public Policy Summit on Lupus will serve as an advocacy forum for more than 200 lupus activists from throughout the country. The summit will present the importance of lupus research to Congress and seek to elevate the disease on the nation’s health care agenda. Furthermore, participants will advocate for expanded funding for lupus research conducted by the National Institutes of Health.

The National Public Policy Summit on Lupus will take place June 26 and 27 at the Hyatt Regency on Capitol Hill in Washington, DC. Participants must register by June 2.